SIA
ZBH icon

Stancorp Investment Advisers’s Zimmer Biomet ZBH Stock Holding History

Stancorp Investment Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$75K Hold
657
– – 0.04% 245
2014
Q4 		$72K Buy
+657
New +$69.3K 0.03% 235

Other funds holding ZBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Stancorp Investment Advisers's ZBH Position: Q1 2015 in Review

Stancorp Investment Advisers held its Zimmer Biomet (ZBH) position steady in Q1 2015 at 657 shares worth $75K. The position accounts for 0.04% of the portfolio, ranked #245.

Stancorp Investment Advisers first reported a position in ZBH in Q4 2014 and has held it in 2 quarters since. 762 funds tracked by Wall St. Rank hold ZBH as of Q1 2015.

  • Stancorp Investment Advisers held 657 shares of Zimmer Biomet worth $75K as of Q1 2015.
  • Stancorp Investment Advisers left its Zimmer Biomet share count unchanged in Q1 2015.
  • Zimmer Biomet made up 0.04% of Stancorp Investment Advisers's portfolio in Q1 2015, its #245 holding.
  • Stancorp Investment Advisers first reported a position in Zimmer Biomet in Q4 2014 and has held it in 2 quarters since.
  • 762 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.